Pilot Study: Safety of Chlorhexidine (CHG) Baths in Patients Less Than 2 Months of Age
Sponsor: Celeste Chandonnet
This PHASE1 trial investigates Chlorhexidine Allergy and Infection and is currently completed. Celeste Chandonnet leads this study, which shows 11 recorded versions since 2016 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Dec 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Sep 2021 — Dec 2021 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE1
▶ Show 6 earlier versions
-
Sep 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1
-
Apr 2019 — Sep 2020 [monthly]
Active Not Recruiting PHASE1
-
Jun 2018 — Apr 2019 [monthly]
Active Not Recruiting PHASE1
-
Dec 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Feb 2017 — Dec 2017 [monthly]
Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1
First recorded
Feb 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Celeste Chandonnet
For direct contact, visit the study record on ClinicalTrials.gov .